This inventor holds 1 USPTO granted patent. Top assignee: Enumeral Biomedical Holdings, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Bin Feng and His Patent in Antibody Innovation.
Introduction
Bin Feng is an inventor associated with New York, New York, and Enumeral Biomedical Holdings, Inc. His listed patent concerns anti-PD-1 antibodies, an area of research focused on immune checkpoint biology.
Latest Patents
Feng is credited with 1 patent: “Anti-PD-1 Antibodies.” The patent title indicates work involving antibodies that target PD-1, a protein studied in immunotherapy research.
Career Highlights
The available information connects Feng’s inventive work with Enumeral Biomedical Holdings, Inc. His listed patent reflects a contribution to antibody-related innovation.
Collaborations
Feng’s listed coworkers include Najmia Amirina and Hareesh Chamarthi. Their names provide context for the professional network associated with his work.
Conclusion
Bin Feng’s recorded patent activity centers on anti-PD-1 antibodies and links his inventive work to Enumeral Biomedical Holdings, Inc.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile